Li Yi-Nan, Zhou Li-Xin, Fang Bing, Mao Ke-Jiang, Wen Wei-Biao, Yu Tie-Ou, Zou Yi-Cheng, Li Wen-Yan, Li Chang
Intensive Care Unit, Foshan First People's Hospital, Foshan 528000, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Jul;29(7):1372-4.
To explore the changes of CD(14)(+) monocyte human leucocyte antigen DR (HLA-DR) and their relationship with multiple organ dysfunction syndrome (MODS) in severe sepsis.
Ninety-one patients with a definite diagnosis of severe sepsis in the intensive care unit (ICU) were included. CD(14)(+) monocyte HLA-DR levels were detected by flow cytometry on the first, 4th and 7th days of the study, and Marshall scores and prognosis on day 28 were evaluated.
Thirty-four patients died within 28 days following the onset with a mortality rate of 37.4%. Persistently lowered levels of HLA-DR were detected and significantly increased Marshall scores were found in the fatal cases at all the time points (P<0.001). In the surviving patients, the levels of HLA-DR were significantly increased (P<0.01) and Marshall scores were gradually decreased (P<0.001). During the observation period, the levels of HLA-DR decreased significantly as the number of dysfunctional organs and Marshall scores increased (P<0.001). The levels of HLA-DR were significantly increased in severe sepsis patients with 2-4 dysfunctional organs and Marshall score of 5-12 (P<0.05 or P<0.001). No changes in HLA-DR levels in severe sepsis patients with 5-6 dysfunctional organs and Marshall scores of 13-22. The levels of HLA-DR showed a significant inverse correlation to Marshall scores (r=-0.368, P<0.001).
In patients with severe sepsis, persistent low CD(14)(+) monocyte HLA-DR levels predicts high mortality. The levels of HLA-DR are significantly correlated to the severity of organ dysfunction.
探讨严重脓毒症患者CD14(+)单核细胞人类白细胞抗原DR(HLA-DR)的变化及其与多器官功能障碍综合征(MODS)的关系。
纳入重症监护病房(ICU)中确诊为严重脓毒症的91例患者。在研究的第1天、第4天和第7天通过流式细胞术检测CD14(+)单核细胞HLA-DR水平,并评估第28天的Marshall评分和预后。
34例患者在发病后28天内死亡,死亡率为37.4%。在所有时间点,死亡病例中均检测到HLA-DR水平持续降低,且Marshall评分显著升高(P<0.001)。存活患者中,HLA-DR水平显著升高(P<0.01),Marshall评分逐渐降低(P<0.001)。在观察期内,随着功能障碍器官数量和Marshall评分的增加,HLA-DR水平显著降低(P<0.001)。在有2-4个功能障碍器官且Marshall评分为5-12的严重脓毒症患者中,HLA-DR水平显著升高(P<0.05或P<0.001)。在有5-6个功能障碍器官且Marshall评分为13-22的严重脓毒症患者中,HLA-DR水平无变化。HLA-DR水平与Marshall评分呈显著负相关(r=-0.368,P<0.001)。
在严重脓毒症患者中,持续低水平的CD14(+)单核细胞HLA-DR预示着高死亡率。HLA-DR水平与器官功能障碍的严重程度显著相关。